Welcome to the e-CCO Library!

N01: Does physical activity positively impact fatigue in individuals with Inflammatory Bowel Disease?
Year: 2021
Source: 15th N-ECCO Network Meeting
Authors: Dawn Farrell
Created: Friday, 1 October 2021, 12:41 PM
Background

Patients with Inflammatory Bowel Disease (IBD) often experience the problematic and burdensome symptom of fatigue, both during periods of relapse and remission. The optimal management of fatigue in IBD is uncertain, however there is evidence suggesting that physical activity is likely to be a beneficial way of managing the symptom. The aim of this study is to explore the relationship between fatigue and objective measurements of both physical activity metrics and varying intensities of physical activity for individuals with IBD.

Methods

A multi-centred, European, cross-sectional, correlational study was employed. A consecutive sample of 187 patients with Crohn’s disease (59%) or ulcerative colitis (41%) were recruited from six IBD centres in the Republic of Ireland (42%), United Kingdom (40%) and Denmark (18%). Fatigue was measured using the IBD-Fatigue (IBD-F) scale, including both the level of fatigue (IBD-F, Section 1) and impact of fatigue (IBD-F, Section 2). Physical activity was objectively measured using scientifically validated triaxial accelerometers (ActiGraph wGT3X-BT) during seven consecutive days.

Results

A moderate level of fatigue (IBD-F Section 1 Md (IQR) = 10 (6 – 13)), predominantly intermittent in nature (72%) was reported by participants (57.4% female; 59% Crohn’s disease; 43% active disease). Participants self-reported sleeping an average of 8.7 hours over the seven nights. During the week, the intensity of activity was predominantly sedentary (Md 5 days, 22 hours, 20 minutes) or light (Md 19 hours, 35 minutes). The median moderate-to-vigorous intensity of physical activity per day was 32.2 minutes and step count over the week was 47052 steps. There was no evidence of a unique linear or non-linear relationship between each of the objective measurements of physical activity with IBD-related fatigue. This lack of evidence extended separately to patients in remission and to patients with active disease. These findings are in the context of a statistically significant moderately-strong relationship between disease activity (measured using both HBI and SCCAI) and level of fatigue for both patients of Crohn’s disease (rs = .327, p = .001, n = 96) and ulcerative colitis (rs = .353, p = .003, n = 71).

Conclusion

This large multi-centred study shows no association between objective measurements of physical activity and IBD-fatigue. These findings suggest that engaging or not engaging in physical activity has no differential impact on self-assessment of fatigue.

N01: Fatigue and physical activity in individuals with inflammatory bowel disease: a feasibility cross-sectional, correlational study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

D. Farrell*1, C. Byron2, M. Forry3, N. Godwin3, C. Judge4

Created: Friday, 22 February 2019, 9:41 AM
N01: Fatigue and physical activity in individuals with Inflammatory Bowel Disease: A feasibility cross-sectional, correlational study
Year: 2019
Source: 13th N-ECCO Network Meeting
Authors: Dawn Farrell
Created: Tuesday, 28 May 2019, 3:32 PM
Fatigue
Files: 1
N01: Type of patient education impacts the willingness to switch from an IV to SC of a biological in patients with Inflammatory Bowel Disease: a multicentre, comparative study.
Year: 2022
Source: ECCO'22
Authors: De Dycker, E.(1);Hoefkens, E.(2);Asnong, K.(2);Geens, P.(1);Lembrechts, N.(2);Lambrechts, T.(1);Van de Schoot, I.(2);Paps, A.(2);Vermeire, S.(1);Pouillon, L.(2);Ferrante, M.(1);Bossuyt, P.(2);
Created: Friday, 11 February 2022, 3:52 PM
N01: Using Item Response Theory to improve the efficiency of the Crohn and Colitis Knowledge score for patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Comoretto, R.(1);Azzolina, D.(2);Monaco, E.(3);Martinato, M.(3)*;
Created: Friday, 14 July 2023, 10:43 AM
N02 Please refer to N02 in the chapter for ‘Nurses poster presentations’
Year: 2020
Source:

ECCO'20 Vienna

Created: Thursday, 30 January 2020, 10:12 AM
N02 The IBD-BOOST programme: developing a digital self-management intervention for symptoms of fatigue, pain and urgency in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Windgassen1, M. Artom2, C. Norton3, L. Sweeney3, R. Moss-Morris2

Created: Thursday, 30 January 2020, 10:12 AM
N020: "What do you think about it?" The adolescent's voice affected by IBD
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Zaniboni*, S. Cozza, P. Lionetti

Created: Thursday, 21 February 2019, 9:14 AM
N021: Medication adherence and medication beliefs among women with inflammatory bowel disease in reproductive age
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Tsavdaroglou1*, P. Karantzas2, A. Tsavdaroglou3, R. Horne4, H. Brokalaki5, G.J. Mantzaris2

Created: Thursday, 21 February 2019, 9:14 AM
N022: The influence of children's inflammatory bowel disease (IBD) on the relationship between parents and their married life-preliminary results
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Kotkowicz-Szczur*, M. Matuszczyk, J. Kierkuś

Created: Thursday, 21 February 2019, 9:14 AM
N023: Characterisation of IBD patients with multiple sclerosis at a large IBD unit
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Breiteneicher*, H.P. Török, J. Mayerle, F. Beigel

Created: Thursday, 21 February 2019, 9:14 AM
N024: Changing face of care for patients with moderate-to-severe inflammatory bowel disease: The role of specialist nurses in the governance of anti-TNFα prescribing in Romania
Year: 2018
Source: ECCO '18 Vienna
Authors:

A.S. Leca1*, O. Timofte2, D. Mihnea3, N. Melinte3, G.G. Balan2,3, C. Stanciu3

Created: Thursday, 21 February 2019, 9:14 AM
N025: Diversity at the workplace and responsibility at work positively impact the tendency towards own professional marketing among nurses in gastroenterology
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Barkan1*, I. Goren1,2, H. Iting3, I. Kagan4, R. Kigli4, K. Rabinowitz2,5, I. Dotan1,2, H. Yanai1,2

Created: Thursday, 21 February 2019, 9:14 AM
N026: IBDoc® self-care/point-of-care calportectin test: Early value in a district general hospital inflammatory bowel disease service
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Avery1*, R. Wilson1,2

Created: Thursday, 21 February 2019, 9:14 AM
N027: Telephone/email service provided to IBD patients by Canadian IBD nurses
Year: 2018
Source: ECCO '18 Vienna
Authors:

U. Chauhan1*, O.–I. Nistor2, B. Currie3, J. Nicholl4, W. McCaw5, M. Watson6, L. Westin7, A. Fernandes8, C. Norton9

Created: Thursday, 21 February 2019, 9:14 AM
N029: Patients experience of advice received on the use of topical therapies in inflammatory bowel disease (IBD)
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Tyrrell1*, L. Whitley2, J. Adio3, K. Greveson4, A. Hall5, H. Yarrow6, L. Medcalf7, H. Parker2

Created: Thursday, 21 February 2019, 9:14 AM
N02: Inflammatory bowel disease and pregnancy: the impact of education in knowledge and attitude of women in reproductive age; one-year follow-up study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Tsavdaroglou*1, G. Mantzaris2, A. Tsavdaroglou3, N. Fotos4, H. Brokalaki4

Created: Friday, 22 February 2019, 9:41 AM
N02: Our life is a roller-coaster! A qualitative phenomenological study exploring the impact of IBD on family members
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Thapwong, P.(1)*;Norton , C.(1);Rowland, E.(2);Czuber-dochan, W.(1);
Created: Friday, 14 July 2023, 10:43 AM
N02: PREVIEW study: Factors associated with willingness to switch from intravenous to subcutaneous formulations of CT-P13 and vedolizumab in patients with Inflammatory Bowel Disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: Asnong, K.(1);Hoefkens, E.(1);Lembrechts, N.(1);Van de Schoot, I.(1);Pouillon, L.(1);Bossuyt, P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM